Mon, March 4, 2024
Fri, March 1, 2024
Thu, February 29, 2024

Oren Livnat Maintained (VRCA) at Strong Buy with Increased Target to $13 on, Mar 1st, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-13-on-mar-1st-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Oren Livnat of HC Wainwright & Co., Maintained "Verrica Pharmaceuticals Inc." (VRCA) at Strong Buy with Increased Target from $12 to $13 on, Mar 1st, 2024.

Oren has made no other calls on VRCA in the last 4 months.



There is 1 other peer that has a rating on VRCA. Out of the 1 peers that are also analyzing VRCA, 0 agree with Oren's Rating of Hold.



This is the rating of the analyst that currently disagrees with Oren


  • Glen Santangelo of "Jefferies" Reiterated at Strong Buy and Held Target at $10 on, Friday, December 15th, 2023

Publication Contributing Sources